Skip to main content

Advertisement

Table 2 Results of some of the recent clinical experience with Mammosite Brachytherapy System with more than a year follow up.

From: Accelerated Partial Breast Irradiation (APBI): A review of available techniques

Author No of cases Median follow up interval(months) IBF Good/Excellent cosmesis
Benitez et al.[73] 43 65 0% 81.3%
Niehoff et al [69] 11 20 0% n/a
Patel et al.[75] 26 48.5 0% n/a
Vicini et al.[71] 1440 30 1.6% 95%
Chen et al.[76] 70 26.1 5.7% n/a
Belkacemi et al. [77] 25 13 0% 84%
Voth et al.[78] 55 24 3.6% n/a
Dragun et al. [70] 90 24 2.2% 90%
Vicini et al.[79] 1440 60 2.6% 90.6%
Jeruss et al. [74] 194$ 54.4 3.1% 92%
  1. n/a data not available, IBF = ipsilateral breast failure, $ these are ductal carcinoma in situ (DCIS) patients recruited in the American Society of Breast Surgeons APBI registry trial